(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one

C26H27FN10O4 — CID 131913566

IUPAC(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
SMILESO=C1N[C@H]2CN(C(=O)CCCn3nnc(-c4ccc(F)cc4)n3)C[C@@H]2OCc2cn(nn2)CCOc2cccnc21
InChIInChI=1S/C26H27FN10O4/c27-18-7-5-17(6-8-18)25-31-34-37(32-25)10-2-4-23(38)35-14-20-22(15-35)41-16-19-13-36(33-30-19)11-12-40-21-3-1-9-28-24(21)26(39)29-20/h1,3,5-9,13,20,22H,2,4,10-12,14-16H2,(H,29,39)/t20-,22-/m0/s1
InChIKeyOYYSPXLAMCCXLU-UNMCSNQZSA-N
MW562.57 g/mol
LogP0.86
Rot. Bonds5

About (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one

(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one (PubChem CID 131913566) has the molecular formula C26H27FN10O4 and a molecular weight of 562.57 g/mol. Its IUPAC name is (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one.

Molecular Properties

Compound Name(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
PubChem CID131913566
Molecular FormulaC26H27FN10O4
Molecular Weight562.57 g/mol
Exact Mass562.22
IUPAC Name(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
SMILESO=C1N[C@H]2CN(C(=O)CCCn3nnc(-c4ccc(F)cc4)n3)C[C@@H]2OCc2cn(nn2)CCOc2cccnc21
InChIInChI=1S/C26H27FN10O4/c27-18-7-5-17(6-8-18)25-31-34-37(32-25)10-2-4-23(38)35-14-20-22(15-35)41-16-19-13-36(33-30-19)11-12-40-21-3-1-9-28-24(21)26(39)29-20/h1,3,5-9,13,20,22H,2,4,10-12,14-16H2,(H,29,39)/t20-,22-/m0/s1
InChIKeyOYYSPXLAMCCXLU-UNMCSNQZSA-N
XLogP0.86
TPSA155.07 Ų
H-Bond Donors1
H-Bond Acceptors12
Rotatable Bonds5
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500562.57
LogP ≤ 50.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1012

Analyze (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(4S,8S)-6-[2-(6-chloro-2,3-dihydro-1,4-benzodioxin-7-yl)acetyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131944493
(4S,8S)-6-(2-propylpentanoyl)-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131906791
(4S,8S)-6-[2-(2-methylphenyl)sulfanylacetyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131926994
(4S,8S)-6-[3-[3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131915317
(4S,8S)-6-(5-ethylthiophene-2-carbonyl)-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131922820
(4S,8S)-6-[2-(3,4,5-trimethoxyphenyl)acetyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131942139
(4S,8S)-6-(4-propylpyrimidine-5-carbonyl)-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131917635
(4S,8S)-6-(3,5,7-trimethyl-1H-indole-2-carbonyl)-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131934940
(4S,8S)-6-(1-propylpyrazol-4-yl)sulfonyl-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one
CID 131933463
(4S,8S)-6-[4-(1,2,4-triazol-1-yl)butanoyl]-9,18-dioxa-3,6,12,13,14-pentazatetracyclo[17.3.1.111,14.04,8]tetracosa-1(23),11(24),12,19,21-pentaen-2-one
CID 135110111
(4S,8S)-19-methoxy-6-[2-(4-oxo-1-pyridinyl)acetyl]-9,17-dioxa-3,6,12,13,14-pentazatetracyclo[16.3.1.111,14.04,8]tricosa-1(22),11(23),12,18,20-pentaen-2-one
CID 131892238
(3S,7S)-5-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-13-methoxy-2,15-dioxa-5,8,18-triazatetracyclo[18.2.2.110,14.03,7]pentacosa-1(23),10(25),11,13,20(24),21-hexaene-9,17-dione
CID 164690588

Frequently Asked Questions

What is the IUPAC name of (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one?
The IUPAC name of (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one (CID 131913566) is (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one.
What is the SMILES notation for (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one?
The canonical SMILES for (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one is O=C1N[C@H]2CN(C(=O)CCCn3nnc(-c4ccc(F)cc4)n3)C[C@@H]2OCc2cn(nn2)CCOc2cccnc21.
What is the InChIKey of (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one?
The InChIKey is OYYSPXLAMCCXLU-UNMCSNQZSA-N. The full InChI is InChI=1S/C26H27FN10O4/c27-18-7-5-17(6-8-18)25-31-34-37(32-25)10-2-4-23(38)35-14-20-22(15-35)41-16-19-13-36(33-30-19)11-12-40-21-3-1-9-28-24(21)26(39)29-20/h1,3,5-9,13,20,22H,2,4,10-12,14-16H2,(H,29,39)/t20-,22-/m0/s1.
What are the key properties of (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one?
(4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one has a molecular weight of 562.57 g/mol, XLogP of 0.86, 5 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,8S)-6-[4-[5-(4-fluorophenyl)tetrazol-2-yl]butanoyl]-3,17-dioxa-6,9,12,20,21,22-hexazatetracyclo[18.2.1.04,8.011,16]tricosa-1(23),11(16),12,14,21-pentaen-10-one is sourced from PubChem (CID 131913566), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).